Search research articles
Contact Us
Filters
Showing results (301-310 of 1,016) with videos related to
Page
of 102
Sort By:
Journal of Natural Products
|
August 13, 2010
Alcoholysis of naturally occurring imides: misleading interpretation of antifungal activities
Thomas Pacher, Adriane Raninger, Eberhard Lorbeer, et al.
The American Journal of Pathology
|
September 24, 2013
Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrier
Slava Rom, Viviana Zuluaga-Ramirez, Holly Dykstra, et al.
Journal of Molecular and Cellular Cardiology
|
April 27, 2005
Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes
B Pesse, S Levrand, F Feihl, et al.
Acta Physiologica Hungarica
|
January 1, 1996
Electrophysiological characteristics of ventricular muscles from diabetic hearts
V Kecskeméti, P Pacher, G Szalai, et al.
Circulation
|
February 22, 2001
Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure
R Berger, B Stanek, M Hülsmann, et al.
International Journal of Molecular Medicine
|
November 17, 2001
Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro
A Marton, P Pacher, K G Murthy, et al.
Wiener Klinische Wochenschrift
|
January 20, 1984
[Causes of death in patients with pacemakers - with respect to the indication for implantation]
C Müller, D Glogar, M Schemper, et al.
The Journal of Heart Valve Disease
|
November 1, 1993
Doppler sonographic evaluation of the Duromedics-Edwards bileaflet valve at five-year follow up
S Globits, S Rödler, A Moritz, et al.
Pacing and Clinical Electrophysiology : PACE
|
January 1, 1995
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program
B Frey, M Wutte, R Berger, et al.
Wiener Klinische Wochenschrift
|
September 25, 1998
[Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure]
M Wutte, M Hülsmann, R Berger, et al.
Page
of 102
Search research articles
Search
Showing results (301-310 of 1,016) with videos related to
Sort By:
Page
of 102
Journal of Natural Products
|
August 13, 2010
Alcoholysis of naturally occurring imides: misleading interpretation of antifungal activities
Thomas Pacher, Adriane Raninger, Eberhard Lorbeer, et al.
The American Journal of Pathology
|
September 24, 2013
Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrier
Slava Rom, Viviana Zuluaga-Ramirez, Holly Dykstra, et al.
Journal of Molecular and Cellular Cardiology
|
April 27, 2005
Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes
B Pesse, S Levrand, F Feihl, et al.
Acta Physiologica Hungarica
|
January 1, 1996
Electrophysiological characteristics of ventricular muscles from diabetic hearts
V Kecskeméti, P Pacher, G Szalai, et al.
Circulation
|
February 22, 2001
Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure
R Berger, B Stanek, M Hülsmann, et al.
International Journal of Molecular Medicine
|
November 17, 2001
Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro
A Marton, P Pacher, K G Murthy, et al.
Wiener Klinische Wochenschrift
|
January 20, 1984
[Causes of death in patients with pacemakers - with respect to the indication for implantation]
C Müller, D Glogar, M Schemper, et al.
The Journal of Heart Valve Disease
|
November 1, 1993
Doppler sonographic evaluation of the Duromedics-Edwards bileaflet valve at five-year follow up
S Globits, S Rödler, A Moritz, et al.
Pacing and Clinical Electrophysiology : PACE
|
January 1, 1995
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program
B Frey, M Wutte, R Berger, et al.
Wiener Klinische Wochenschrift
|
September 25, 1998
[Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure]
M Wutte, M Hülsmann, R Berger, et al.
Page
of 102